BioCentury
ARTICLE | Clinical News

INKP-100 sodium phosphate tablets: INKP began two U.S. Phase III trials

October 26, 1998 8:00 AM UTC

InKine Pharmaceutical Co. Inc. (INKP), Blue Bell, Penn. Product: INKP-100 sodium phosphate tablets Indication: Purgative agent for bowel preparation prior to colonoscopy Status: INKP began two U.S. P...